Additionally, the IMPACT (Identification of Men with a genetic predisposition to ProstAte Cancer) study proposed annual PSA screening in the population with germline breast cancer 1/2 early-onset (BRCA1/2) and prostate biopsy if PSA level above 3 ng mL−1 [4]. The gene discussed is KLK3; the disease is prostate carcinoma.